𝔖 Bobbio Scriptorium
✦   LIBER   ✦

479. Expression of the apoptosis inhibitors p53, bcl-2, EGFR and survivin in renal cell carcinomas: Correlation with pathological features and clinical outcome

✍ Scribed by Contis, J.; Lykoudis, P.; Nastos, C.; Karakatsanis, A.; Dellaportas, D.; Delis, A.; Karandrea, D.; Pafiti-Kondi, A.


Book ID
126698035
Publisher
Elsevier Science
Year
2014
Tongue
English
Weight
25 KB
Volume
40
Category
Article
ISSN
0748-7983

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Mutation of p53 in head and neck squamou
✍ Genevieve A. Andrews; Sichuan Xi; Rebecca G. Pomerantz; Charles J. Lin; William πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 English βš– 515 KB

## Abstract ## Background. The p53 protein, a well‐known tumor suppressor that functions primarily as a transcription factor, initiates cell cycle arrest and apoptosis after genotoxic stress. The antiapoptotic regulator Bcl‐2 is a downstream modulator of p53‐induced apoptosis. Loss of function of